Cytena Founds Subsidiary in Taiwan

24-Jul-2019 - Taiwan

Cytena is continuing its growth with the establishment of its subsidiary Cytena bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development

"With the new R&D focused company, we want to further strengthen our global market position and open up new application areas and target markets. Our team in Taipei will enable us to be even closer to our Asian partners and use local R&D and production resources," says Dr. Jonas Schoendube, CEO of Cytena in Germany.

Cytena Bioprocess Solutions will focus on providing bioprocess solutions for pharmaceutical companies and leading research institutes.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Bayer invests USD 50 Million in eGenesis Series B financing round - Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

Bayer invests USD 50 Million in eGenesis Series B financing round - Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

Removab Approval: Proof-of-Concept for Technology Transfer in Germany

Decoding Blood Platelet Production: The Intricate Role of Lipids - Disruptions in lipid metabolism might affect platelet production

Decoding Blood Platelet Production: The Intricate Role of Lipids - Disruptions in lipid metabolism might affect platelet production

Excessive fluid consumption: habit or hormonal disorder? - Which test provides a reliable diagnosis?

Excessive fluid consumption: habit or hormonal disorder? - Which test provides a reliable diagnosis?

Molecular switch may serve as new target point for cancer and diabetes therapies

Molecular switch may serve as new target point for cancer and diabetes therapies

HIV/AIDS long-term costs high - and unaffordable to most-affected countries

Part of hagfish slime mystery solved

Effects of chemical mixtures: Neurotoxic effects add up - Study demonstrates for the first time the toxicological relevance of chemical mixtures as they occur in humans

Effects of chemical mixtures: Neurotoxic effects add up - Study demonstrates for the first time the toxicological relevance of chemical mixtures as they occur in humans

Innovative approach to treat autism spectrum disorders - University of Basel spin-off Translation-X receives Venture Kick funding

Innovative approach to treat autism spectrum disorders - University of Basel spin-off Translation-X receives Venture Kick funding

Shifting meetings, conventions online curbs climate change - The annual carbon footprint for the global event and convention industry is on par with the yearly greenhouse gas emissions of the entire U.S.

Shifting meetings, conventions online curbs climate change - The annual carbon footprint for the global event and convention industry is on par with the yearly greenhouse gas emissions of the entire U.S.

Photocure announces positive results of Phase 2B study evaluating Visonac in acne